SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-16-006300
Filing Date
2016-06-21
Accepted
2016-06-21 21:43:33
Documents
2
Period of Report
2016-06-18

Document Format Files

Seq Description Document Type Size
1 form3-06212016_060621.html 3  
1 form3-06212016_060621.xml 3 1707
2 ex24-06212016_060621.htm EX-24 5357
  Complete submission text file 0001415889-16-006300.txt   8492
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-244-9990
VistaGen Therapeutics, Inc. (Issuer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Smith Mark Alan (Reporting) CIK: 0001677452 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37761 | Film No.: 161725526